Annual EBIT
-$2.18 M
-$2000.00-0.09%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual earnings before interest & taxes is -$2.18 million, with the most recent change of -$2000.00 (-0.09%) on December 31, 2023.
- During the last 3 years, MACK annual EBIT has risen by +$2.84 million (+56.58%).
Performance
MACK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$669.00 K
-$179.00 K-36.53%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly earnings before interest & taxes is -$669.00 thousand, with the most recent change of -$179.00 thousand (-36.53%) on March 1, 2024.
- Over the past year, MACK quarterly EBIT has dropped by -$138.00 thousand (-25.99%).
Performance
MACK Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$2.26 M
-$83.00 K-3.81%
March 1, 2024
Summary
- As of February 10, 2025, MACK TTM earnings before interest & taxes is -$2.26 million, with the most recent change of -$83.00 thousand (-3.81%) on March 1, 2024.
- Over the past year, MACK TTM EBIT has increased by +$34.00 thousand (+1.48%).
Performance
MACK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MACK EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.1% | -26.0% | +1.5% |
| 3 y3 years | +56.6% | -26.0% | +1.5% |
| 5 y5 years | +96.8% | -26.0% | +1.5% |
MACK EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +0.1% | +20.2% | +41.4% | at low | +10.7% | +15.8% |
| 5 y | 5-year | +0.1% | +874.8% | +41.4% | +220.8% | +10.7% | +839.0% |
| alltime | all time | +0.1% | +6658.2% | +41.4% | +8550.1% | +10.7% | +7247.5% |
Merrimack Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$669.00 K(+36.5%) | -$2.26 M(+3.8%) |
| Dec 2023 | -$2.18 M(+0.1%) | -$490.00 K(-7.7%) | -$2.18 M(-5.1%) |
| Sep 2023 | - | -$531.00 K(-6.7%) | -$2.29 M(+1.2%) |
| Jun 2023 | - | -$569.00 K(-2.9%) | -$2.27 M(+3.8%) |
| Mar 2023 | - | -$586.00 K(-3.5%) | -$2.18 M(+0.4%) |
| Dec 2022 | -$2.17 M(-16.9%) | -$607.00 K(+20.4%) | -$2.17 M(+6.6%) |
| Sep 2022 | - | -$504.00 K(+3.7%) | -$2.04 M(-5.3%) |
| Jun 2022 | - | -$486.00 K(-15.8%) | -$2.15 M(-11.9%) |
| Mar 2022 | - | -$577.00 K(+22.0%) | -$2.45 M(-6.5%) |
| Dec 2021 | -$2.62 M(-47.8%) | -$473.00 K(-23.6%) | -$2.62 M(-13.6%) |
| Sep 2021 | - | -$619.00 K(-20.4%) | -$3.03 M(-11.4%) |
| Jun 2021 | - | -$778.00 K(+4.3%) | -$3.42 M(-10.6%) |
| Mar 2021 | - | -$746.00 K(-15.8%) | -$3.82 M(-23.7%) |
| Dec 2020 | -$5.01 M(-76.4%) | -$886.00 K(-12.0%) | -$5.01 M(-20.1%) |
| Sep 2020 | - | -$1.01 M(-14.9%) | -$6.27 M(+5.1%) |
| Jun 2020 | - | -$1.18 M(-38.8%) | -$5.97 M(-54.7%) |
| Mar 2020 | - | -$1.94 M(-9.8%) | -$13.17 M(-37.9%) |
| Dec 2019 | -$21.21 M(-68.6%) | -$2.15 M(+204.4%) | -$21.21 M(-38.3%) |
| Sep 2019 | - | -$705.00 K(-91.6%) | -$34.35 M(-31.7%) |
| Jun 2019 | - | -$8.38 M(-16.0%) | -$50.32 M(-15.7%) |
| Mar 2019 | - | -$9.98 M(-34.7%) | -$59.70 M(-11.6%) |
| Dec 2018 | -$67.51 M(-19.4%) | -$15.29 M(-8.3%) | -$67.51 M(-3.3%) |
| Sep 2018 | - | -$16.67 M(-6.2%) | -$69.82 M(+18.4%) |
| Jun 2018 | - | -$17.77 M(-0.1%) | -$58.95 M(-20.7%) |
| Mar 2018 | - | -$17.78 M(+1.0%) | -$74.31 M(-11.3%) |
| Dec 2017 | -$83.75 M(-43.0%) | -$17.61 M(+203.7%) | -$83.75 M(-22.4%) |
| Sep 2017 | - | -$5.80 M(-82.5%) | -$107.95 M(-21.3%) |
| Jun 2017 | - | -$33.12 M(+21.7%) | -$137.21 M(-1.9%) |
| Mar 2017 | - | -$27.23 M(-34.9%) | -$139.86 M(-4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$147.06 M(+2.1%) | -$41.80 M(+19.3%) | -$147.06 M(-9.8%) |
| Sep 2016 | - | -$35.05 M(-2.0%) | -$163.12 M(-1.7%) |
| Jun 2016 | - | -$35.77 M(+3.9%) | -$165.98 M(+11.7%) |
| Mar 2016 | - | -$34.42 M(-40.5%) | -$148.62 M(+3.2%) |
| Dec 2015 | -$144.06 M(+120.5%) | -$57.87 M(+52.6%) | -$144.06 M(+58.1%) |
| Sep 2015 | - | -$37.91 M(+105.8%) | -$91.11 M(+18.9%) |
| Jun 2015 | - | -$18.42 M(-38.3%) | -$76.65 M(+6.5%) |
| Mar 2015 | - | -$29.87 M(+507.9%) | -$71.95 M(+10.1%) |
| Dec 2014 | -$65.33 M(-45.4%) | -$4.91 M(-79.1%) | -$65.33 M(-26.0%) |
| Sep 2014 | - | -$23.45 M(+70.9%) | -$88.28 M(-12.3%) |
| Jun 2014 | - | -$13.72 M(-41.0%) | -$100.65 M(-13.1%) |
| Mar 2014 | - | -$23.24 M(-16.6%) | -$115.89 M(-3.2%) |
| Dec 2013 | -$119.75 M(+31.3%) | -$27.87 M(-22.2%) | -$119.75 M(+3.0%) |
| Sep 2013 | - | -$35.82 M(+23.7%) | -$116.22 M(+12.0%) |
| Jun 2013 | - | -$28.96 M(+6.8%) | -$103.72 M(+9.3%) |
| Mar 2013 | - | -$27.10 M(+11.4%) | -$94.90 M(+4.1%) |
| Dec 2012 | -$91.20 M(+14.5%) | -$24.34 M(+4.4%) | -$91.20 M(+8.8%) |
| Sep 2012 | - | -$23.32 M(+15.8%) | -$83.82 M(+5.9%) |
| Jun 2012 | - | -$20.14 M(-13.9%) | -$79.14 M(-10.5%) |
| Mar 2012 | - | -$23.40 M(+38.0%) | -$88.42 M(+12.6%) |
| Dec 2011 | -$79.66 M(+71.6%) | -$16.96 M(-9.0%) | -$78.55 M(+9.7%) |
| Sep 2011 | - | -$18.64 M(-36.7%) | -$71.63 M(+9.4%) |
| Jun 2011 | - | -$29.42 M(+117.5%) | -$65.49 M(+36.2%) |
| Mar 2011 | - | -$13.53 M(+34.7%) | -$48.10 M(+3.6%) |
| Dec 2010 | -$46.43 M(-2.4%) | -$10.04 M(-19.6%) | -$46.43 M(+27.6%) |
| Sep 2010 | - | -$12.49 M(+3.8%) | -$36.39 M(+52.3%) |
| Jun 2010 | - | -$12.04 M(+1.4%) | -$23.90 M(+101.4%) |
| Mar 2010 | - | -$11.86 M | -$11.86 M |
| Dec 2009 | -$47.57 M | - | - |
FAQ
- What is Merrimack Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual EBIT year-on-year change?
- What is Merrimack Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly EBIT year-on-year change?
- What is Merrimack Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals TTM EBIT year-on-year change?
What is Merrimack Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of MACK is -$2.18 M
What is the all time high annual EBIT for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual earnings before interest & taxes is -$2.17 M
What is Merrimack Pharmaceuticals annual EBIT year-on-year change?
Over the past year, MACK annual earnings before interest & taxes has changed by -$2000.00 (-0.09%)
What is Merrimack Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of MACK is -$669.00 K
What is the all time high quarterly EBIT for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$473.00 K
What is Merrimack Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, MACK quarterly earnings before interest & taxes has changed by -$138.00 K (-25.99%)
What is Merrimack Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of MACK is -$2.26 M
What is the all time high TTM EBIT for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high TTM earnings before interest & taxes is -$2.04 M
What is Merrimack Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, MACK TTM earnings before interest & taxes has changed by +$34.00 K (+1.48%)